← Leaderboards
Jingfang Ju
Northport Va Medical Center
$4,265,891
Attributed
$4,265,891
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $637K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,265,891 · 4
VA$0 · 1
By mechanism
R01$3,332,444 · 2
R33$674,020 · 1
R21$259,427 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceColon CarcinomaGenesChemotherapyCancer Stem CellBaseCd44 GeneKnock-DownMicrornasTumorCell Cycle RegulationCancer CellResistance MechanismFluorouracilMouse ModelIn VivoPathway InteractionsThymidylate SynthaseNovel StrategiesCellsMalignant NeoplasmsMessenger RnaAcuteTumorigenesis
Grant awards (18)
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer$0
I01 · FY2025 · VA · contact PI
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer$0
I01 · FY2024 · VA · contact PI
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer$0
I01 · FY2023 · VA · contact PI
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer$0
I01 · FY2022 · VA · contact PI
Roles of miR-129 in colorecal cancer$359,202
R01 · FY2020 · CA · contact PI
Roles of miR-129 in colorecal cancer$348,425
R01 · FY2019 · CA · contact PI
Roles of miR-129 in colorecal cancer$359,202
R01 · FY2018 · CA · contact PI
Roles of miR-129 in colorecal cancer$359,202
R01 · FY2017 · CA · contact PI
Roles of miR-129 in colorecal cancer$359,202
R01 · FY2016 · CA · contact PI
Molecular Mechanism of miR-140 in Colon Cancer$375,023
R01 · FY2014 · CA · contact PI
Molecular Mechanism of miR-140 in Colon Cancer$366,685
R01 · FY2013 · CA · contact PI
Identification of post-transcriptionally regulated targets by TrIP-Chip/Seq$216,770
R33 · FY2013 · CA · contact PI
Molecular Mechanism of miR-140 in Colon Cancer$393,528
R01 · FY2012 · CA · contact PI
Identification of post-transcriptionally regulated targets by TrIP-Chip/Seq$232,250
R33 · FY2012 · CA · contact PI
Molecular Mechanism of miR-140 in Colon Cancer$411,975
R01 · FY2011 · CA · contact PI
Identification of post-transcriptionally regulated targets by TrIP-Chip/Seq$225,000
R33 · FY2011 · CA · contact PI
Novel Method for Isolating Actively Translated mRNAs$128,027
R21 · FY2007 · CA · contact PI
Novel Method for Isolating Actively Translated mRNAs$131,400
R21 · FY2006 · CA · contact PI